GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » Price-to-Owner-Earnings

Parnax Lab (BOM:506128) Price-to-Owner-Earnings : 32.76 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab Price-to-Owner-Earnings?

As of today (2024-05-26), Parnax Lab's share price is ₹111.40. Parnax Lab's Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹3.40. It's Price-to-Owner-Earnings for today is 32.76.


The historical rank and industry rank for Parnax Lab's Price-to-Owner-Earnings or its related term are showing as below:

BOM:506128' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.07   Med: 18.14   Max: 206.79
Current: 33.43

During the past 13 years, the highest Price-to-Owner-Earnings of Parnax Lab was 206.79. The lowest was 8.07. And the median was 18.14.


BOM:506128's Price-to-Owner-Earnings is ranked worse than
60.19% of 417 companies
in the Drug Manufacturers industry
Industry Median: 27.13 vs BOM:506128: 33.43

As of today (2024-05-26), Parnax Lab's share price is ₹111.40. Parnax Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹7.47. Therefore, Parnax Lab's PE Ratio for today is 14.92.

As of today (2024-05-26), Parnax Lab's share price is ₹111.40. Parnax Lab's EPS without NRI for the trailing twelve months (TTM) ended in was ₹7.61. Therefore, Parnax Lab's PE Ratio without NRI for today is 14.63.

During the past 13 years, Parnax Lab's highest PE Ratio without NRI was 179.09. The lowest was 4.46. And the median was 10.51.


Parnax Lab Price-to-Owner-Earnings Historical Data

The historical data trend for Parnax Lab's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab Price-to-Owner-Earnings Chart

Parnax Lab Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 15.30

Parnax Lab Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 15.30 - - -

Competitive Comparison of Parnax Lab's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnax Lab's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Parnax Lab's Price-to-Owner-Earnings falls into.



Parnax Lab Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Parnax Lab's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=111.40/3.40
=32.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnax Lab  (BOM:506128) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Parnax Lab Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Parnax Lab's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnax Lab (BOM:506128) Business Description

Traded in Other Exchanges
N/A
Address
104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines